Additional file 1: Table S1. of Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C

2017-03-14T05:00:00Z (GMT) by Narasimha Prasad Shammana Muddukrishna
Frequency of subjects and number of recurrences in the two hospital groups using hazard ratio (HR) values reported in Table 1. Table S2. Recurrence rate and median recurrence-free survival) (RFS) for Keyhole Limpet Hemocyanin (KLH) and mitomycin C (MM) for group S1 and group S2. Table S3. Hazard ratio for the same drug product KLH/MM for group S1 relative to group S2. (PDF 148 kb)